Vaping and Teens: Strategies to Help Stem the Tide
- CME / AMA PRA Category 1 Credit™
- CME / AAPA Category 1 CME Credits
- MOC / ABIM MOC Part 2 Credit
- CNE / Nursing Contact Hours
- MIPS Improvement Activity Under MACRA
PROGRAM OVERVIEW
Electronic cigarettes (E-cigarettes) were first introduced into the US in 2007. Since then, there has been a dramatic increase in their use by adolescents and young adults. In 2015, “ever-use” of E-cigarettes reached 40% of middle- and high-school students.
E-cigarettes deliver vaporized solutions containing nicotine or non-nicotine substances for respiratory absorption. A tank or cartridge contains the solution to be vaporized, and each e-cigarette includes a heating element with an electronic power source. While E-cigarettes are marketed as a healthier alternative to smoking, their use exposes young people to nicotine and its adverse effects (including effects on the developing brain) and to carcinogens produced by the combustion of carrier agents, which may include propylene glycol and/or a vegetable glycerin.
Reports of pulmonary injury, renal disease, increased risk of cardiovascular disease, and a recent death linked to E-cigarettes makes it imperative that clinicians understand these devices and the extent of their use by adolescents and young adults. This activity will prepare clinicians to ask their patients about E-cigarette use, and counsel young people with respect to these devices and their impacts on health.
AGENDA
Welcome and Introductions
Prevalence of E-cigarette Use in Pre-teens and Adolescents
Adverse Events Associated with E-cigarette Use
Counseling Pre-teens and Adolescents on E-cigarette Use
Activity Roundup
TARGET AUDIENCE
This activity is intended for the community-based primary care team, including physicians, physician assistants, and nurse practitioners.
EDUCATIONAL OBJECTIVES
This program is designed to address ACGME and NAM competencies, including delivering patient-centered care and practicing
At the conclusion of this activity, participants should be able to:
- Discuss epidemiologic and sociologic data regarding exposure of pre-teens and adolescents to e-cigarettes
- Recognize adverse events associated with the use of e-cigarettes
- Develop strategies to initiate a discussion about e-cigarettes with pre-teens and adolescents and provide evidence-based education and counseling
ACCREDITATION
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.
CREDIT DESIGNATION
The Potomac Center for Medical Education designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For information about the accreditation of this program, please email: contact@potomacme.org.
FACULTY

Assistant Professor, Department of Pediatrics
Perelman School of Medicine at the University of Pennsylvania
Primary Care Pediatrician and Medical Director, Value‐Based Care
Children’s Hospital of Philadelphia (CHOP)
Philadelphia, PA
Dr. Jenssen was a Clinical and Translational Science Institute Student Fellow through the National Institutes of Health, conducting research in tobacco policy, smoking cessation, and adolescent use of social media. He has worked extensively with the American Academy of Pediatrics (AAP) and the Julius B. Richmond Center of Excellence on a variety of tobacco policy efforts, and currently serves as an executive member of the newly formed AAP Section on Tobacco Control.
He holds a bachelor's degree from Davidson College, received his medical degree from the University of Rochester School of Medicine and Dentistry, and is board-certified in pediatrics. He completed a residency in pediatrics and recently served as Chief Resident at CHOP. From 2014 to 2016, Dr. Jenssen was a Robert Wood Johnson Foundation Clinical Scholar at the University of Pennsylvania, where he also earned his Masters in Health Policy Research.

Scientific Director
American Academy of Pediatrics Julius B. Richmond Center of Excellence
Savithri and Samuel Raj Endowed Professor
Executive Vice Head, Department of Pediatrics
University of Illinois at Chicago School of Medicine
Chicago, IL
Dr. Klein served on the faculty at the University of Rochester from 1992-2009. From 2009-2017, he was Associate Executive Director of the American Academy of Pediatrics and, from 2005-2017, he was the Principal Investigator and founding Director of the American Academy of Pediatrics Julius B. Richmond Center of Excellence, where he currently serves as Scientific Director. The Richmond Center of Excellence is dedicated to protecting children from tobacco and secondhand smoke.
His research addresses access and quality of adolescent healthcare, preventive care delivery, survey methods, and tobacco control. Dr. Klein is immediate past Chair of NCD Child, a global coalition advocating for inclusion of children and youth in the “Non-Communicable Disease (NCD)” and “Sustainable Development Goals (SDGs)” agendas. He also serves as North American Vice President of the International Association for Adolescent Health and as an elected member of the International Pediatric Association Executive Committee.
ABIM MOC DESIGNATION STATEMENT
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
To receive CME credit and/or MOC points, you MUST pass the post-test and complete the evaluation. For ABIM MOC points, your information will be shared with the ABIM through PCME’s ACCME Program and Activity Reporting System (PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.
MIPS CREDIT DESIGNATION STATEMENT
Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS).
AAFP CREDIT DESIGNATION
JOINT PROVIDER STATEMENT
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Rockpointe Corporation. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
NURSING CREDIT DESIGNATION
PHYSICIAN ASSISTANT CREDIT DESIGNATION
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until 1/21/2021. PAs should only claim credit commensurate with the extent of their participation.
DISCLOSURES
All persons in a position to control the content of a continuing medical education program provided by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts of interest are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners. The content of this activity was vetted by an external reviewer to assure objectivity and that the activity is free of commercial bias.
Steering Committee Disclosures
The faculty and steering committee reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:
Brian Jenssen, MD, MSHP: Stock Shareholder: Founder of ProNoto, LLC
Jonathan D. Klein, MD, MPH: Nothing to disclose
Non-faculty Disclosures
Non-faculty content contributors and/or reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:
Terry Ann Glauser, MD, MPH; Blair St. Amand; Lindsay Scott, PT, DPT, ATC; Ashley Marostica, MSN, RN, CCM; Brian Jack, MD; PIM Planners and Managers: Nothing to disclose
FDA DISCLOSURE
SYSTEM REQUIREMENTS
INSTRUCTIONS FOR PARTICIPANTS AND OBTAINING CME CREDIT
PROVIDER
SUPPORTER
This activity is not supported by any commercial interest or grantor.
RELATED COURSES

Opioid Analgesics: Risk Evaluation and Mitigation Strategy (REMS) and the New FDA Blueprint
Credits 3.00 (3 hrs)
Format Webcourse


FIGHTING THE UPHILL BATTLE: Current Evidence in Obesity Management
Credits 1.00 (60 min)
Format Webcourse
Jan